...
首页> 外文期刊>Neoplasma: Journal of Experimental and Clinical Oncology >A note on nucleoli in granulocytic precursors of the granulopoietic proliferating compartment in patients suffering from the chronic phase of chronic myeloid leukemia treated with two different drugs with different mode of action.
【24h】

A note on nucleoli in granulocytic precursors of the granulopoietic proliferating compartment in patients suffering from the chronic phase of chronic myeloid leukemia treated with two different drugs with different mode of action.

机译:关于慢性粒细胞白血病慢性期患者的粒细胞增生区粒细胞前体中核仁的注释,用两种不同作用方式的药物治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

The incidence of main nucleolar types in granulocytic precursors was studied in the granulopoietic proliferating compartment (GPC) of patients suffering from chronic phase of the chronic myeloid leukemia (CML) who were treated by the widely used therapy with two different drugs with different mode of action - hydroxyurea (HU) and interferon alpha (IFN-alpha). In comparison with IFN early stages of GPC, i.e. myeloblasts and promyelocytes in patients treated with HU possessed more frequently micronucleoli which are known to reflect the direct as well as indirect inhibition of the nucleolar biosynthetic activities. On the other hand, the incidence of micronucleoli in these cells of a small percentage of patients treated with IFN also reached the average values of these nucleoli which were noted in patients treated with HU.
机译:在患有慢性粒细胞白血病(CML)慢性期的患者的粒细胞增生区(GPC)中研究了粒细胞前体中主要核仁类型的发生率,这些患者接受了广泛使用的两种不同作用方式药物的治疗-羟基脲(HU)和干扰素α(IFN-α)。与GPC早期的IFN相比,接受HU治疗的患者的成纤维细胞和早幼粒细胞拥有更频繁的微核仁,这些微核仁反映了对核仁生物合成活性的直接和间接抑制。另一方面,在小部分接受IFN治疗的患者中,这些细胞中微核仁的发生率也达到了接受HU治疗的患者中所见核仁的平均值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号